http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 15 Oct 2026 08:30:40 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html <p align="justify">PHILADELPHIA, Oct. 15, 2026 (GLOBE NEWSWIRE) -- <br /></p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html Thu, 15 Oct 2026 08:30:40 -0400 AARD CCB ERAS PSIX http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html <p align="justify">PHILADELPHIA, Oct. 15, 2026 (GLOBE NEWSWIRE) -- <br /></p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html Thu, 15 Oct 2026 08:30:40 -0400 AARD CCB ERAS PSIX http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html <p align="justify">PHILADELPHIA, Oct. 15, 2026 (GLOBE NEWSWIRE) -- <br /></p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html Thu, 15 Oct 2026 08:30:40 -0400 AARD CCB ERAS PSIX http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html <p align="justify">PHILADELPHIA, Oct. 15, 2026 (GLOBE NEWSWIRE) -- <br /></p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html Thu, 15 Oct 2026 08:30:40 -0400 AARD CCB ERAS PSIX http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html <p align="justify">PHILADELPHIA, Oct. 15, 2026 (GLOBE NEWSWIRE) -- <br /></p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html Thu, 15 Oct 2026 08:30:40 -0400 AARD CCB ERAS PSIX http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html <p align="justify">PHILADELPHIA, Oct. 15, 2026 (GLOBE NEWSWIRE) -- <br /></p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html Thu, 15 Oct 2026 08:30:40 -0400 AARD CCB ERAS PSIX http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html <p align="justify">PHILADELPHIA, Oct. 15, 2026 (GLOBE NEWSWIRE) -- <br /></p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html Thu, 15 Oct 2026 08:30:40 -0400 AARD CCB ERAS PSIX http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html <p align="justify">PHILADELPHIA, Oct. 15, 2026 (GLOBE NEWSWIRE) -- <br /></p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html Thu, 15 Oct 2026 08:30:40 -0400 AARD CCB ERAS PSIX http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html <p align="justify">PHILADELPHIA, Oct. 14, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html Wed, 14 Oct 2026 09:53:04 -0400 AARD CCB NEHC NUAI SMPL http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html <p align="justify">PHILADELPHIA, Oct. 14, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html Wed, 14 Oct 2026 09:53:04 -0400 AARD CCB NEHC NUAI SMPL http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html <p align="justify">PHILADELPHIA, Oct. 14, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html Wed, 14 Oct 2026 09:53:04 -0400 AARD CCB NEHC NUAI SMPL http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html <p align="justify">PHILADELPHIA, Oct. 14, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html Wed, 14 Oct 2026 09:53:04 -0400 AARD CCB NEHC NUAI SMPL http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html <p align="justify">PHILADELPHIA, Oct. 14, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html Wed, 14 Oct 2026 09:53:04 -0400 AARD CCB NEHC NUAI SMPL http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html <p align="justify">PHILADELPHIA, Oct. 14, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html Wed, 14 Oct 2026 09:53:04 -0400 AARD CCB NEHC NUAI SMPL http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html <p align="justify">PHILADELPHIA, Oct. 14, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html Wed, 14 Oct 2026 09:53:04 -0400 AARD CCB NEHC NUAI SMPL http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html <p align="justify">PHILADELPHIA, Oct. 14, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html Wed, 14 Oct 2026 09:53:04 -0400 AARD CCB NEHC NUAI SMPL http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html <p align="justify">PHILADELPHIA, Oct. 14, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html Wed, 14 Oct 2026 09:53:04 -0400 AARD CCB NEHC NUAI SMPL http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html <p align="justify">PHILADELPHIA, Oct. 14, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+and+The+Simply+Goo/27185266.html Wed, 14 Oct 2026 09:53:04 -0400 AARD CCB NEHC NUAI SMPL http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Duolingo%2C+Inc.+%28NASDAQ%3A+DUOL%29%3B+and+Ensign+Group%2C+Inc.+%28NASDAQ%3A+ENSG%29%3A+Graba/27172682.html <p align="justify">PHILADELPHIA, Oct. 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Duolingo%2C+Inc.+%28NASDAQ%3A+DUOL%29%3B+and+Ensign+Group%2C+Inc.+%28NASDAQ%3A+ENSG%29%3A+Graba/27172682.html Sat, 10 Oct 2026 10:00:43 -0400 AARD CCB DUOL ENSG http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Duolingo%2C+Inc.+%28NASDAQ%3A+DUOL%29%3B+and+Ensign+Group%2C+Inc.+%28NASDAQ%3A+ENSG%29%3A+Graba/27172682.html <p align="justify">PHILADELPHIA, Oct. 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Duolingo%2C+Inc.+%28NASDAQ%3A+DUOL%29%3B+and+Ensign+Group%2C+Inc.+%28NASDAQ%3A+ENSG%29%3A+Graba/27172682.html Sat, 10 Oct 2026 10:00:43 -0400 AARD CCB DUOL ENSG http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Duolingo%2C+Inc.+%28NASDAQ%3A+DUOL%29%3B+and+Ensign+Group%2C+Inc.+%28NASDAQ%3A+ENSG%29%3A+Graba/27172682.html <p align="justify">PHILADELPHIA, Oct. 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Duolingo%2C+Inc.+%28NASDAQ%3A+DUOL%29%3B+and+Ensign+Group%2C+Inc.+%28NASDAQ%3A+ENSG%29%3A+Graba/27172682.html Sat, 10 Oct 2026 10:00:43 -0400 AARD CCB DUOL ENSG http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Duolingo%2C+Inc.+%28NASDAQ%3A+DUOL%29%3B+and+Ensign+Group%2C+Inc.+%28NASDAQ%3A+ENSG%29%3A+Graba/27172682.html <p align="justify">PHILADELPHIA, Oct. 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Duolingo%2C+Inc.+%28NASDAQ%3A+DUOL%29%3B+and+Ensign+Group%2C+Inc.+%28NASDAQ%3A+ENSG%29%3A+Graba/27172682.html Sat, 10 Oct 2026 10:00:43 -0400 AARD CCB DUOL ENSG http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Duolingo%2C+Inc.+%28NASDAQ%3A+DUOL%29%3B+and+Ensign+Group%2C+Inc.+%28NASDAQ%3A+ENSG%29%3A+Graba/27172682.html <p align="justify">PHILADELPHIA, Oct. 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Duolingo%2C+Inc.+%28NASDAQ%3A+DUOL%29%3B+and+Ensign+Group%2C+Inc.+%28NASDAQ%3A+ENSG%29%3A+Graba/27172682.html Sat, 10 Oct 2026 10:00:43 -0400 AARD CCB DUOL ENSG http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Duolingo%2C+Inc.+%28NASDAQ%3A+DUOL%29%3B+and+Ensign+Group%2C+Inc.+%28NASDAQ%3A+ENSG%29%3A+Graba/27172682.html <p align="justify">PHILADELPHIA, Oct. 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Duolingo%2C+Inc.+%28NASDAQ%3A+DUOL%29%3B+and+Ensign+Group%2C+Inc.+%28NASDAQ%3A+ENSG%29%3A+Graba/27172682.html Sat, 10 Oct 2026 10:00:43 -0400 AARD CCB DUOL ENSG http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Duolingo%2C+Inc.+%28NASDAQ%3A+DUOL%29%3B+and+Ensign+Group%2C+Inc.+%28NASDAQ%3A+ENSG%29%3A+Graba/27172682.html <p align="justify">PHILADELPHIA, Oct. 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Duolingo%2C+Inc.+%28NASDAQ%3A+DUOL%29%3B+and+Ensign+Group%2C+Inc.+%28NASDAQ%3A+ENSG%29%3A+Graba/27172682.html Sat, 10 Oct 2026 10:00:43 -0400 AARD CCB DUOL ENSG